As of April 29, 2025, Palatin Technologies (PTN) has a market cap of $5.331 million USD. According to our data, Palatin Technologies is ranked No.8992 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $5.33 M |
-79.52%
|
Dec 31, 2024 | $26.04 M |
-72.11%
|
Dec 29, 2023 | $93.35 M |
55.47%
|
Dec 30, 2022 | $60.05 M |
-79.92%
|
Dec 31, 2021 | $0.30 B |
-25.00%
|
Dec 31, 2020 | $0.40 B |
-12.82%
|
Dec 31, 2019 | $0.46 B |
9.86%
|
Dec 31, 2018 | $0.42 B |
-17.44%
|
Dec 29, 2017 | $0.50 B |
68.63%
|
Dec 30, 2016 | $0.30 B |
-22.73%
|
Dec 31, 2015 | $0.39 B |
-9.59%
|
Dec 31, 2014 | $0.43 B |
0.00%
|
Dec 31, 2013 | $0.43 B |
21.67%
|
Dec 31, 2012 | $0.35 B |
50.00%
|
Dec 30, 2011 | $0.23 B |
-70.37%
|
Dec 31, 2010 | $0.79 B |
-63.51%
|
Dec 31, 2009 | $2.17 B |
311.11%
|
Dec 31, 2008 | $0.53 B |
-55.00%
|
Dec 31, 2007 | $1.17 B |
-90.20%
|
Dec 29, 2006 | $11.96 B |
-37.42%
|
Dec 30, 2005 | $19.12 B |
22.56%
|
Dec 31, 2004 | $15.60 B |
6.40%
|
Dec 31, 2003 | $14.66 B |
26.26%
|
Dec 31, 2002 | $11.61 B |
-52.86%
|
Dec 31, 2001 | $24.63 B |
24.44%
|
Dec 29, 2000 | $19.79 B |
35.00%
|
Dec 31, 1999 | $14.66 B |
-39.39%
|
Dec 31, 1998 | $24.19 B |
-29.79%
|
Dec 31, 1997 | $34.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
![]() USA
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
![]() USA
|
![]() Merck
MRK
|
$212.01 B |
-0.001 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.59 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
![]() USA
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
![]() UK
|
Market Cap | = | PTN Stock Price | * | PTN Shares Outstanding |
= | $0.20 | * | 26.01 M | |
= | $5.33 M |